The Rapid Influenza Diagnostics Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the future of the healthcare vertical.
According to the World Health Organization (WHO), over 3-5 million were infected by influenza and over 2.9 million to 6.5 million deaths reported, globally. Rapid influenza diagnostics bears edge over other immunoassays by providing rapid results and faster diagnosis.
The global rapid influenza diagnostics market is poised to grow lucratively with the rising prevalence of influenza infections, active R&D investments for novel rapid influenza diagnostics development and high demand for faster diagnosis.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32000
Coronavirus has propelled the global market of rapid influenza diagnostics. Since the coronavirus and influenza belong to the same class of respiratory virus and with similar symptoms, this has pushed the use of rapid influenza diagnostics applicable for massive scale to curb the spread of coronavirus.
However, the global rapid influenza diagnostics market is constrained by its drawbacks of false-negative due to its low to moderate sensitivity and stringent regulatory policies. Although the global rapid influenza diagnostics market growth is promising due to its prevalent use in point-of-care settings.
The active R&D and investments into healthcare. Also, the massive demand, the recent emergence of coronavirus pandemic and the pipeline diagnostic technologies are expected to fuel the rapid influenza diagnostics market growth.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32000
Rapid Influenza Diagnostics Market: Segmentation
By product |
|
By patient |
|
By end-user |
|
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32000
By patient, paediatrics and geriatrics rule the segment due to the high prevalence of influenza in them and need of hospitalization. By end-user, hospitals dominate the segment due to the availability of advanced diagnostics, the rapid need for hospitalization and experienced medical staff and advanced services.
Asia-Pacific rapid influenza diagnostics market is emerging and is growing with the fastest rate due to high prevalence of avian influenza A, demanding for instant testing to curb the infection spread, increasing awareness, advancing R&D and healthcare.
Latin America rapid influenza diagnostics market is growing moderately with improving healthcare and research infrastructure to control the high burden of influenza infection. The Middle East & Africa rapid influenza diagnostics market is stagnant due to the under-developed research and healthcare infrastructure and lack of awareness.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com